Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698994 | Clinical Oncology | 2010 | 8 Pages |
Abstract
For this group of patients, despite the use of recognised dose-volume constraint guidelines of three trials, we were unable to establish a relationship between these constraints and the late rectal toxicity registered. Further studies on the correlation of dosimetric parameters with rectal toxicity, particularly for hypofractionated regimens, are required. Non-dosimetric factors may also be involved in the risk of late rectal toxicity.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Faria, B. Joshua, H. Patrocinio, A. Dal Pra, F. Cury, A.M. Velly, L. Souhami,